Technique may speed drug production, reduce costs and waste

Main Category: Pharma Industry / Biotech Industry
Article Date: 20 Apr 2005 - 0:00 PDT

Current ratings for:
'Technique may speed drug production, reduce costs and waste'

Patient / Public:not yet rated

Healthcare Prof:not yet rated


University of Toronto researchers have a developed a new chemical reaction that could greatly accelerate pharmaceutical production, while also cutting costs and toxic by-products.

The reaction, designed by chemistry Professor Mark Lautens and graduate student Eric Fang, simplifies the creation of the basic molecular framework found in many natural products and popular pharmaceuticals like some cholesterol-lowering drugs. Until now, synthesizing this framework - an indole - was inefficient, requiring six to 10 steps and often producing toxic by-products. "This new method only takes three steps and results in less waste," says Lautens, the NSERC-Merck Frosst Industrial Research Chair in New Medicinal Agents via Catalytic Reactions and AstraZeneca Professor of Organic Synthesis.

Indoles are ring structures containing carbon and nitrogen. In the process, the researchers used a metallic element as a catalyst to form two chemical bonds and create a diverse range of indole-containing compounds. These compounds could then be used to make drugs now on the market or form the basis of new therapeutic drugs.

Lautens says this new molecular-level technique could equal big savings and less environmental impact. "In order to make a hundred kilograms of these best-selling drugs, there are often hundreds of litres of solvent used, not to mention the many purification processes involved. Not only are you speeding up the process, you're also reducing waste and energy used in manufacturing."

A provisional patent was filed by U of T's Innovations Foundation in March. The research was funded by the Natural Sciences and Engineering Research Council of Canada.

CONTACT: Professor Mark Lautens, U of T Department of Chemistry, 416-978-6083, mlautens@chem.utoronto.ca, or Karen Kelly, U of T Public Affairs, 416-978-6974, k.kelly@utoronto.ca

For the latest U of T news, visit the news and events website at: http://www.utoronto.ca For U of T experts, see the Blue Book Online at: http://www.library.utoronto.ca/bluebook

Contact: Prof. Mark Lautens
416-978-6083
University of Toronto
http://www.utoronto.ca

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Prof. Mark Lautens. "Technique may speed drug production, reduce costs and waste." Medical News Today. MediLexicon, Intl., 20 Apr. 2005. Web.
26 May. 2012. <http://www.medicalnewstoday.com/releases/23082.php>

APA
Prof. Mark Lautens. (2005, April 20). "Technique may speed drug production, reduce costs and waste." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/23082.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Technique may speed drug production, reduce costs and waste'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »